Abstract

Although used for over 100 years, allergen immunotherapy (AIT) is still an indispensable tool in modern allergy managemen20t due to its potential to cure allergic diseases. Its current rapid development through the application of personalized and precision medicine approaches is strongly supported by advances in mHealth, component-resolved diagnosis (CRD)-based diagnostics, validation of novel biomarkers, advanced data management, and development of novel preparations. This review summarizes the key advances in the field and shows the perspectives for further development of next-generation AIT treatments.

Author Details

Authors

• Magdalena Zemelka-Wiacek¹
• Marek Jutel¹,²

Departments

• ¹ Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, and
• ² ALL-MED Medical Research Institute, Wroclaw, Poland

Address

Marek Jutel and Magdalena Zemelka-Wiacek, Department of Clinical Immunology, Wroclaw Medical University, Parkowa 34, 51-616 Wroclaw, Poland
Email: [email protected]

Citation